digiMedical Solutions, Inc. Signs Contract With Dr. Steven Bello to Implement Digital Prescription Software and Reauthorization
August 27 2008 - 10:16AM
Marketwired
digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that
the Company has signed a contract with Dr. Steven Bello of Collier
Otolaryngology in Naples, Florida to implement the Company's
proprietary .Net-based digital prescription handling software,
digiRX and digiReauth, and to supply call center services to
support the reauthorization of prescriptions. Dr. Bello's practice
chose digiMedical's digital prescription software to improve office
efficiency and free up personnel's time to see patients and for the
safety the digitized prescriptions provide to both their patients
and the physicians. Additionally, Dr. Bello's practice enjoys the
customer service the reauthorization call center provides their
patients because they talk to a person to renew prescriptions.
Earlier this year, digiMedical announced efforts to expand the
Company's sales in Florida by signing contracts with doctors and
clinics to implement the Company's proprietary digital prescription
software and reauthorization call center services. Since launching
those efforts, they have signed contracts with multiple doctors in
Florida to include: Dr. Richard Wilson, Drs. Angela Marshall, Wendy
Humphrey and Betsy Brothers of Southwest Florida Women's Group,
P.A., Dr. Daniel Kaplan, Dr. Moorthy of Pain Management Center of
Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology,
Drs. Romero, Tineo and Seibert of Oaktree Family Practice,
Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs.
Santos-Ocampo, Axline and Spilker of the Collier Heart Group, Dr.
John Landi, the Medical Director of Vanish Vein and Laser Center
and Dr. Wey of the Neuroscience and Spine Associates in Naples,
Florida, among others.
digiMedical's Prescription Handling Software
digiMedical has built a suite of proprietary software to
digitally manage prescriptions in both doctor and clinic offices
and in pharmacies. The digital prescriptions are routed directly
and securely from the physician's office or clinic to the pharmacy.
The digital pack of information also already contains pertinent
patient information, allowing the pharmacy to pre-fill the
prescription prior to the patient's arrival at the pharmacy.
The Company's digital prescription software suite meets HIPAA
and DEA requirements and protects the pharmacist from errors caused
by difficult-to-read handwritten prescriptions and the risk to the
pharmacist of illegally duplicated prescriptions and fraudulent
prescriptions. Additionally, digiMedical manages prescription
refills for physicians' offices and clinics through the Company's
digiReauth software and call center services. The suite of software
includes digiRX, digiRxStream, digiReauth, digiRxComp, and
digiAccounting.
Company Updates and Information
digiMedical's software, which is currently in use in pharmacies
in Naples and Ft. Meyers, Florida, and in Dallas, Texas, is now
available for implementation nationwide in independent and chain
pharmacies. If you are interested in learning more about
digiMedical's software, or implementing the Company's proprietary
technology in your pharmacy, please contact the Company at
sales@digimedical.com or 1-877-450-8181.
To be added to digiMedical's corporate e-mail list for
shareholders and interested investors or to request additional
information about the Company, please send an e-mail to
ir@digimedical.com.
About digiMedical Solutions, Inc.(TM)
digiMedical Solutions, Inc.(TM) (www.digimedical.com) is a
pharmacy and medical technology company focused on developing next
generation digital medical technology with an emphasis on digital
prescriptions (d-Prescriptions) that will more closely align the
doctor, pharmacist and patient. The Company's digital prescription
handling software captures and transmits prescriptions digitally
from the physician's office to the pharmacy, securely and in
compliance with all DEA and HIPAA requirements. The suite of
software includes digiRX, digiRxStream, digiReauth, digiRxComp, and
digiAccounting.
Forward-Looking Statement
Statements included in this press release which are not
historical in nature, are intended to be, and are hereby identified
as "Forward-Looking Statements" for purposes of safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-Looking Statements may be identified by words
including "anticipate," "await," "envision," "foresee," "aim at,"
"believe," "intends," "estimates" including without limitation,
those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's
filings with the U.S. Securities and Exchange Commission for
additional information and a presentation of the risks and
uncertainties that may affect the company's business and results of
operations.
Contact: digiMedical Solutions, Inc. Investor Relations
ir@digimedical.com 214-722-3029 Sales: sales@digimedical.com
1-877-450-8181
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From May 2024 to Jun 2024
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From Jun 2023 to Jun 2024